Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from WuXi XDC Cayman, Inc. ( (HK:2268) ).
WuXi XDC Cayman Inc. announced the successful passing of a resolution at their Extraordinary General Meeting held on October 9, 2025. The resolution involved a subscription agreement with WuXi Biologic (Cayman) Inc. for the issuance of 24,134,000 new shares at HK$58.85 per share, which was unanimously approved by the shareholders. This agreement is expected to strengthen WuXi XDC’s capital base and enhance its strategic positioning in the market.
The most recent analyst rating on (HK:2268) stock is a Buy with a HK$90.00 price target. To see the full list of analyst forecasts on WuXi XDC Cayman, Inc. stock, see the HK:2268 Stock Forecast page.
More about WuXi XDC Cayman, Inc.
Average Trading Volume: 6,902,853
Technical Sentiment Signal: Buy
Current Market Cap: HK$103.1B
For an in-depth examination of 2268 stock, go to TipRanks’ Overview page.